{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:37:46Z","timestamp":1772080666408,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA097257"],"award-info":[{"award-number":["P50 CA097257"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00401-023-02641-6","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:01:28Z","timestamp":1697043688000},"page":"857-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis"],"prefix":"10.1007","volume":"146","author":[{"given":"Merryl","family":"Terry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Ravindranathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Bollen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchel S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-7999","authenticated-orcid":false,"given":"David A.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"2641_CR1","first-page":"2298","volume":"58","author":"M Bahuau","year":"1998","unstructured":"Bahuau M, Vidaud D, Jenkins RB, Bi\u00e8che I, Kimmel DW, Assouline B et al (1998) Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58:2298\u20132303","journal-title":"Cancer Res"},{"key":"2641_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1101\/gad.186601","volume":"15","author":"S Britsch","year":"2001","unstructured":"Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA et al (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15:66\u201378. https:\/\/doi.org\/10.1101\/gad.186601","journal-title":"Genes Dev"},{"key":"2641_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00381-017-3340-2","volume":"33","author":"R Caltabiano","year":"2017","unstructured":"Caltabiano R, Magro G, Polizzi A, Pratico AD, Ortensi A, D\u2019Orazi V et al (2017) A mosaic pattern of INI1\/SMARCB1 protein expression distinguishes schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst 33:933\u2013940. https:\/\/doi.org\/10.1007\/s00381-017-3340-2","journal-title":"Childs Nerv Syst"},{"key":"2641_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","volume":"139","author":"S Coy","year":"2020","unstructured":"Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S (2020) An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol 139:643\u2013665. https:\/\/doi.org\/10.1007\/s00401-019-02029-5","journal-title":"Acta Neuropathol"},{"key":"2641_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.200912142","volume":"189","author":"M Finzsch","year":"2010","unstructured":"Finzsch M, Schreiner S, Kichko T, Reeh P, Tamm ER, Bosl MR et al (2010) Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol 189:701\u2013712. https:\/\/doi.org\/10.1083\/jcb.200912142","journal-title":"J Cell Biol"},{"key":"2641_CR6","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1038\/s41388-020-1374-5","volume":"39","author":"DL Helbing","year":"2020","unstructured":"Helbing DL, Schulz A, Morrison H (2020) Pathomechanisms in schwannoma development and progression. Oncogene 39:5421\u20135429. https:\/\/doi.org\/10.1038\/s41388-020-1374-5","journal-title":"Oncogene"},{"key":"2641_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJ Hulsebos","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805\u2013810. https:\/\/doi.org\/10.1086\/513207","journal-title":"Am J Hum Genet"},{"key":"2641_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-020-02230-x","volume":"141","author":"S Mansouri","year":"2021","unstructured":"Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141:101\u2013116. https:\/\/doi.org\/10.1007\/s00401-020-02230-x","journal-title":"Acta Neuropathol"},{"key":"2641_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/ejhg.2014.220","volume":"23","author":"I Paganini","year":"2015","unstructured":"Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L et al (2015) Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet 23:963\u2013968. https:\/\/doi.org\/10.1038\/ejhg.2014.220","journal-title":"Eur J Hum Genet"},{"key":"2641_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","volume":"46","author":"A Piotrowski","year":"2014","unstructured":"Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46:182\u2013187. https:\/\/doi.org\/10.1038\/ng.2855","journal-title":"Nat Genet"},{"key":"2641_CR11","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24:1967\u20131977. https:\/\/doi.org\/10.1016\/j.gim.2022.05.007","journal-title":"Genet Med"},{"key":"2641_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/jci130206","volume":"130","author":"B Rivera","year":"2020","unstructured":"Rivera B, Nadaf J, Fahiminiya S, Apellaniz-Ruiz M, Saskin A, Chong AS et al (2020) DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. J Clin Invest 130:1479\u20131490. https:\/\/doi.org\/10.1172\/jci130206","journal-title":"J Clin Invest"},{"key":"2641_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.2621","author":"MR Sargen","year":"2023","unstructured":"Sargen MR, Kim J, Potjer TP, Velthuizen ME, Martir-Negron AE, Odia Y et al (2023) Estimated prevalence, tumor spectrum, and neurofibromatosis type 1-like phenotype of CDKN2A-related melanoma-astrocytoma syndrome. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2023.2621","journal-title":"JAMA Dermatol"},{"key":"2641_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/humu.20679","volume":"29","author":"R Sestini","year":"2008","unstructured":"Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29:227\u2013231. https:\/\/doi.org\/10.1002\/humu.20679","journal-title":"Hum Mutat"},{"key":"2641_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10048-012-0319-8","volume":"13","author":"MJ Smith","year":"2012","unstructured":"Smith MJ, Wallace AJ, Bowers NL, Rustad CF, Woods CG, Leschziner GD et al (2012) Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics 13:141\u2013145. https:\/\/doi.org\/10.1007\/s10048-012-0319-8","journal-title":"Neurogenetics"},{"key":"2641_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90501-g","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791\u2013800. https:\/\/doi.org\/10.1016\/0092-8674(93)90501-g","journal-title":"Cell"},{"key":"2641_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/neuros\/nyaa455","volume":"88","author":"HN Vasudevan","year":"2021","unstructured":"Vasudevan HN, Lucas CG, Villanueva-Meyer JE, Theodosopoulos PV, Raleigh DR (2021) Genetic events and signaling mechanisms underlying Schwann cell fate in development and cancer. Neurosurgery 88:234\u2013245. https:\/\/doi.org\/10.1093\/neuros\/nyaa455","journal-title":"Neurosurgery"},{"key":"2641_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad121","author":"EA Williams","year":"2023","unstructured":"Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noad121","journal-title":"Neuro Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02641-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-023-02641-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02641-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T15:02:21Z","timestamp":1699282941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-023-02641-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2641"],"URL":"https:\/\/doi.org\/10.1007\/s00401-023-02641-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.A.S. is a member of the editorial board of <i>Acta Neuropathologica<\/i> but was not involved in the handling or decision making for this manuscript. The remaining authors declare that they have no competing interests related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Committee on Human Research of the University of California, San Francisco, with a waiver of patient consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}